Literature DB >> 8531156

Factors to consider in selecting an occlusal concept for patients with implants in the edentulous mandible.

D Wismeijer1, M A van Waas, W Kalk.   

Abstract

This article discusses the occlusal concepts when making implant-supported and implant-retained mandibular overdentures. The dentate or edentulous condition of the maxilla plays a significant role in this respect. If the maxilla is edentulous, balanced occlusion is indicated. In a maxillary Kennedy class I or II situation, either group function or balanced occlusion is advocated depending on the characteristics of the opposing dentition. When a complete dentition is present in the maxilla or in the case of a Kennedy class III or IV situation, mutually protected occlusion or group function is recommended depending on the length, position, and number of implants. It is stressed that detailed preimplant placement diagnosis and treatment planning are essential to obtain a high standard of treatment with overdentures supported and retained by implants.

Entities:  

Mesh:

Year:  1995        PMID: 8531156     DOI: 10.1016/s0022-3913(05)80378-6

Source DB:  PubMed          Journal:  J Prosthet Dent        ISSN: 0022-3913            Impact factor:   3.426


  3 in total

1.  An international multicenter study on the effectiveness of a denture adhesive in maxillary dentures using disposable gnathometers.

Authors:  Cees de Baat; Martin van't Hof; Lieve van Zeghbroeck; Mutlu Ozcan; Warner Kalk
Journal:  Clin Oral Investig       Date:  2007-03-13       Impact factor: 3.573

2.  Experience with bruxism in the everyday oral implantology practice in the Netherlands: a qualitative study.

Authors:  Magdalini Thymi; Annemiek Rollman; Corine M Visscher; Daniel Wismeijer; Frank Lobbezoo
Journal:  BDJ Open       Date:  2018-11-09

3.  Strain Distribution in a Kennedy Class I Implant Assisted Removable Partial Denture under Various Loading Conditions.

Authors:  Reza Shahmiri; John M Aarts; Vincent Bennani; Raj Das; Michael V Swain
Journal:  Int J Dent       Date:  2013-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.